TargED closes seed investment and partners with UMC Utrecht for the development of Microlyse – a next-generation thrombolytic clot-busting drug
We are excited to share that TargED Biopharmaceuticals, a spin-off from the UMC Utrecht, has entered into a License and Collaboration agreement with UMC Utrecht and closed a seed round,…